Search

Author/Creator Verzoni, E.

1. 2603 Complete remission (CR) during treatment for metastatic renal cell carcinoma (mRCC) with tyrosine kinase inhibitors (TKIs). (September 2015)

Authors:
Santini, D.; Santoni, M.; Conti, A.; Procopio, G.; Verzoni, E.; Galli, L.; Di Lorenzo, G.; De Giorgi, U.; De Lisi, D.; Nicodemo, M.; Maruzzo, M.; Massari, F.; Buti, S.; Biasco, E.; Ricotta, R.; Porta, C.; Vincenzi, B.; Marchetti, P.; Cascinu, S.; Tonini, G.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S512
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 889PBroad immunomodulating effect of first-line pazopanib in metastatic renal cell carcinoma patients. (18th September 2017)

Authors:
Verzoni, E.; De Cecco, L.; Dugo, M.; Rinchai, D.; Bedognetti, D.; Grassi, P.; Ratta, R.; Cova, A.; Squarcina, P.; Huber, V.; Montone, R.; Sorrentino, M.; Procopio, G.; Rivoltini, L.
Journal:
Annals of oncology
Issue:
Volume 28(2017)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial. Issue 2 (1st February 2021)

Authors:
Mennitto, A.; Verzoni, E.; Cognetti, F.; Miceli, R.; Milella, M.; Mosca, A.; Chiuri, V. E.; Bearz, A.; Morelli, F.; Ortega, C.; Atzori, F.; Donini, M.; Claps, M.; Guadalupi, V.; Sepe, P.; Cappelletti, V.; de Braud, F. G.; Procopio, G.
Journal:
Expert review of clinical pharmacology
Issue:
Volume 14:Issue 2(2021)
Page Start:
261
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗